{"product_id":"abbott-immunoassay-reagent-advisedx-antibody-test-sars-cov-2-igg-ii-for-alinity-i-system-200-tests-6-6-ml-microparticles-6-1-ml-conjugate-8-3-ml-diluent-kt-1-06s6120-kt","title":"Abbott Immunoassay Reagent AdviseDx Antibody Test SARS-CoV-2 IgG II For Alinity i System 200 Tests 6.6 mL Microparticles, 6.1 mL Conjugate, 8.3 mL Diluent - KT\/1 - 06S6120-KT","description":"\u003ch3\u003eAbbott Immunoassay Reagent AdviseDx Antibody Test SARS-CoV-2 IgG II For Alinity i System 200 Test...\u003c\/h3\u003e\u003ctable class=\"tblSimple\" summary=\"Product Attributes\"\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003eItem Id\u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e1187911\u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003eMF Id#\u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e06S6120\u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003eBrand\u003c\/td\u003e \u003ctd class=\"attrDat\"\u003eAdviseDx\u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003eManufacturer\u003c\/td\u003e \u003ctd class=\"attrDat\"\u003eAbbott\u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003eCountry of Origin\u003c\/td\u003e \u003ctd class=\"attrDat\"\u003eIreland\u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Application \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e Immunoassay Reagent \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e For Use With \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e For Alinity i System \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Is_Active_Vendor \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e Y \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Is_DSCSA \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e N \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Is_Discontinued \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e N \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Is_Medical_Device \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e N \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Lot_Tracking_Flag \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e N \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Number of Tests \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e 200 Tests \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e On_Allocation \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e N \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Product Dating \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e McKesson Acceptable Dating: we will ship \u0026gt;= 90 days \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Sample Type \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e Serum \/ Plasma Sample \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Storage Requirements \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e Requires Refrigeration \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Supplier_ID \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e 4446496 \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Test Format \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e Cartridge \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Test Method \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e Chemiluminescent Microparticle Immunoassay (CMIA) \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Test Name \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e SARS-CoV-2 IgG II \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Test Type \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e Antibody Test \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e UNSPSC Code \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e 41116020 \u003c\/td\u003e \u003c\/tr\u003e \u003ctr\u003e \u003ctd class=\"attrTitle\"\u003e Volume \u003c\/td\u003e \u003ctd class=\"attrDat\"\u003e 6.6 mL Microparticles, 6.1 mL Conjugate, 8.3 mL Diluent \u003c\/td\u003e \u003c\/tr\u003e \u003c\/table\u003e \u003ch4 id=\"prodfeats\"\u003eFeatures\u003c\/h4\u003e\u003cul id=\"itemFeatures\" class=\"unordered-list\"\u003e \u003cli\u003eThe AdviseDx SARS-CoV-2 IgG II assay is for use under an Emergency Use Authorization Only: https:\/\/www.fda.gov\/medical-devices\/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices\/in-vitro-diagnostics-euas#individual-serological\u003c\/li\u003e\n\u003cli\u003eTesting is limited to laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) of 1988, 42 U.S.C 263a, that meet requirements to perform moderate or high complexity tests\u003c\/li\u003e\n\u003cli\u003eLaboratories within the United States and its territories are required to report all results to the appropriate public health authorities\u003c\/li\u003e\n\u003cli\u003eThe AdviseDx SARS-CoV-2 IgG II assay is a chemiluminescent microparticle immunoassay (CMIA) intended for the qualitative and semi-quantitative detection of IgG antibodies to SARS CoV-2 in human serum (including collected using a serum separator tube) and plasma (acid citrate dextrose, sodium citrate, dipotassium EDTA, tripotassium EDTA, lithium heparin, lithium heparin in a separator tube, and sodium heparin) on the Alinity i system\u003c\/li\u003e\n\u003cli\u003eAt this time, it is unknown for how long antibodies persist following infection and if the presence of antibodies confers protective immunity\u003c\/li\u003e\n\u003cli\u003eThe AdviseDx SARS-CoV-2 IgG II assay should not be used to diagnose or exclude acute SARS-CoV-2 infection\u003c\/li\u003e\n\u003cli\u003eA positive result may not indicate previous SARS-CoV-2 infection; consider other information, including clinical history and local disease prevalence, in assessing the need for a second but different serology test to confirm an immune response\u003c\/li\u003e\n\u003cli\u003eA negative result for an individual subject indicates the absence of detectable anti-SARS CoV-2 antibodies; Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions\u003c\/li\u003e\n\u003cli\u003eA negative result can occur if the quantity of the anti-SARS-CoV-2 antibodies in the specimen is below the detection limits of the assay, or if the antibodies are not present during the stage of disease in which a sample is collected\u003c\/li\u003e \u003c\/ul\u003e","brand":"Abbott","offers":[{"title":"Default Title","offer_id":50904833196332,"sku":"06S6120-KT","price":2454.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.healthcareorigin.com\/products\/abbott-immunoassay-reagent-advisedx-antibody-test-sars-cov-2-igg-ii-for-alinity-i-system-200-tests-6-6-ml-microparticles-6-1-ml-conjugate-8-3-ml-diluent-kt-1-06s6120-kt","provider":"Healthcare Origin","version":"1.0","type":"link"}